CRONOS GROUP INC. Selling and Marketing Expense
CRONOS GROUP INC. (CRON) reported Selling and Marketing Expense of $6.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-06
- CRONOS GROUP INC. selling and marketing expense for the quarter ending 2026-06-30 was $6.79M, a 26.89% increase year-over-year.
- CRONOS GROUP INC. selling and marketing expense for the quarter ending 2026-03-31 was $5.62M, a 23.00% increase year-over-year.
- CRONOS GROUP INC. selling and marketing expense for the quarter ending 2025-12-31 was $6.55M, a 2.15% increase year-over-year.
- CRONOS GROUP INC. selling and marketing expense for the quarter ending 2025-09-30 was $5.30M, a 4.11% decline year-over-year.
- CRONOS GROUP INC. selling and marketing expense for fiscal 2025 was $21.76M, a 0.75% increase from fiscal 2024.
- CRONOS GROUP INC. selling and marketing expense for fiscal 2024 was $21.60M, a 4.84% decline from fiscal 2023.
- CRONOS GROUP INC. selling and marketing expense for fiscal 2023 was $22.70M, a 25.80% increase from fiscal 2022.
- CRONOS GROUP INC. selling and marketing expense for fiscal 2022 was $18.05M, a 13.73% decline from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.79M 10-Q · filed 2026-08-06 | $12.40M 10-Q · filed 2026-08-06 | $18.95M derived: sum of 3 quarters · filed 2026-08-06 | $24.25M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $5.62M 10-Q · filed 2026-05-11 | $12.17M derived: sum of 2 quarters · filed 2026-05-11 | $17.47M derived: sum of 3 quarters · filed 2026-05-11 | $22.81M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.85M derived: sum of 2 quarters · filed 2026-02-26 | $17.20M derived: sum of 3 quarters · filed 2026-08-06 | $21.76M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $5.30M 10-Q · filed 2025-11-06 | $10.65M derived: sum of 2 quarters · filed 2026-08-06 | $15.21M 10-Q · filed 2025-11-06 | $21.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $5.35M 10-Q · filed 2026-08-06 | $9.91M 10-Q · filed 2026-08-06 | $16.32M derived: sum of 3 quarters · filed 2026-08-06 | $21.85M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $4.57M 10-Q · filed 2026-05-11 | $10.98M derived: sum of 2 quarters · filed 2026-05-11 | $16.51M derived: sum of 3 quarters · filed 2026-05-11 | $20.84M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $6.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.94M derived: sum of 2 quarters · filed 2026-02-26 | $16.27M derived: sum of 3 quarters · filed 2026-02-26 | $21.60M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $5.53M 10-Q · filed 2025-11-06 | $9.86M derived: sum of 2 quarters · filed 2025-11-06 | $15.19M 10-Q · filed 2025-11-06 | $21.56M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $4.33M 10-Q · filed 2025-08-07 | $9.66M 10-Q · filed 2025-08-07 | $16.03M derived: sum of 3 quarters · filed 2026-02-26 | $21.32M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $5.33M 10-Q · filed 2025-05-08 | $11.70M derived: sum of 2 quarters · filed 2026-02-26 | $17.00M derived: sum of 3 quarters · filed 2026-02-26 | $22.29M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.66M derived: sum of 2 quarters · filed 2026-02-26 | $16.96M derived: sum of 3 quarters · filed 2026-02-26 | $22.70M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $5.30M 10-Q · filed 2024-11-12 | $10.59M derived: sum of 2 quarters · filed 2024-11-12 | $16.33M 10-Q · filed 2024-11-12 | $21.94M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $5.30M 10-Q · filed 2024-08-08 | $11.04M 10-Q · filed 2024-08-08 | $16.64M derived: sum of 3 quarters · filed 2025-02-27 | $21.89M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $5.74M 10-Q · filed 2024-05-09 | $5.87M 10-Q · filed 2023-05-09 | $11.35M derived: sum of 2 quarters · filed 2025-02-27 | $16.59M derived: sum of 3 quarters · filed 2025-02-27 | $20.78M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $10.85M derived: sum of 2 quarters · filed 2025-02-27 | $15.04M derived: sum of 3 quarters · filed 2025-02-27 | $18.05M 10-K · filed 2025-02-27 | $22.28M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $5.25M 10-Q · filed 2023-11-08 | $5.92M 10-Q · filed 2022-11-07 | $9.43M derived: sum of 2 quarters · filed 2023-11-08 | $12.44M 10-Q · filed 2023-11-08 | $16.52M 10-Q · filed 2022-11-07 | $1.08M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $4.18M 10-Q · filed 2023-08-08 | $5.58M 10-Q · filed 2022-08-09 | $7.20M 10-Q · filed 2023-08-08 | $10.59M 10-Q · filed 2022-08-09 | -$4.17M derived: sum of 3 quarters · filed 2024-02-29 | $6.65M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $5.01M 10-Q · filed 2023-05-09 | -$8.36M derived: sum of 2 quarters · filed 2024-02-29 | $2.47M derived: sum of 3 quarters · filed 2024-02-29 | $15.68M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | -$13.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$2.55M derived: sum of 2 quarters · filed 2024-02-29 | $10.66M derived: sum of 3 quarters · filed 2024-02-29 | $20.92M 10-K · filed 2024-02-29 | $44.94M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $10.82M 10-Q · filed 2022-11-07 | $24.03M derived: sum of 2 quarters · filed 2022-11-07 | $34.28M 10-Q · filed 2022-11-07 | $47.82M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $13.21M 10-Q · filed 2022-08-09 | $23.46M 10-Q · filed 2022-08-09 | $37.00M derived: sum of 3 quarters · filed 2023-02-28 | $44.24M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $10.25M 10-Q · filed 2022-05-10 | $23.79M derived: sum of 2 quarters · filed 2023-02-28 | $31.03M derived: sum of 3 quarters · filed 2023-02-28 | $37.53M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $13.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $20.77M derived: sum of 2 quarters · filed 2023-02-28 | $27.27M derived: sum of 3 quarters · filed 2023-02-28 | $34.39M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $7.24M 10-Q · filed 2022-02-18 | $13.74M derived: sum of 2 quarters · filed 2022-02-18 | $20.85M 10-Q · filed 2022-02-18 | $34.17M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $6.50M 10-Q/A · filed 2022-02-18 | $6.50M 10-Q · filed 2020-08-06 | $13.61M 10-Q/A · filed 2022-02-18 | $13.62M 10-Q · filed 2020-08-06 | $26.94M derived: sum of 3 quarters · filed 2022-03-01 | $31.53M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $7.11M 10-Q · filed 2021-05-07 | $20.44M derived: sum of 2 quarters · filed 2022-03-01 | $25.03M derived: sum of 3 quarters · filed 2022-03-01 | $29.03M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $13.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $17.92M derived: sum of 2 quarters · filed 2022-03-01 | $21.92M derived: sum of 3 quarters · filed 2022-03-01 | $23.05M 10-K · filed 2022-03-01 | $23.05M 10-K/A · filed 2020-03-30 | |||
| 2019-09-30 | $4.59M 10-Q · filed 2020-11-05 | $8.60M derived: sum of 2 quarters · filed 2020-11-05 | $9.72M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $4.00M 10-Q · filed 2020-08-06 | $5.13M 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $1.13M 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | $2.54M 10-K · filed 2021-02-26 | $3.17M 10-K/A · filed 2020-03-30 | ||||||
| 2017-12-31 | $443.00K 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |